Fate Therapeutics logo

Fate Therapeutics

San Diego, CA

Fate Therapeutics, Inc. provides biotechnology services. The Company researches and develops therapies to repair and regenerate body tissues with the help of stem cells. Fate Therapeutics conducts business in the United States.

fatetherapeutics.com

Company Details

Founded

2007

Employees

181 employees

Raised

$1,348,828,288

Headquarters Location

San Diego, CA

Public

Yes

Acquired

No

CEO

Scott WolchkoScott Wolchko

Founders

Randall T. Moon
Randall T. Moon
Rudolf Jaenisch
Rudolf Jaenisch
Michael Rudnicki
Michael Rudnicki
Leonard Zon
Leonard Zon
David Scadden
David Scadden
Sheng Ding
Sheng Ding
Alex Rives
Alex Rives
Phillip Beachy
Phillip Beachy

Company Collections

These are collections Fate Therapeutics is a part of. Click on the collection name to view similar companies.

Current Job Listings

Listing 0 of 4 job openings

    Fate Therapeutics Headquarters Location

    12278 Scripps Summit Drive, San Diego, CA 92131

    Total Amount Raised: $1,348,828,288

    Fate Therapeutics Funding Rounds

    • Grant

      $7,900,000

      Grant Investors

      California Institute for Regenerative Medicine (CIRM)
    • Post Ipo Equity

      $100,000,000

      Post Ipo Equity Investors

      OrbiMed Advisors
      Adage Capital Management
      Suvretta Capital Management
      Boxer Capital
      Deep Track Capital
    • Post Ipo Equity

      $432,000,000

    • Post Ipo Equity

      $201,300,000

    • Post Ipo Equity

      $173,000,000

    • Post Ipo Equity

      $172,500,000

    • Grant

      $4,000,000

      Grant Investors

      California Institute for Regenerative Medicine (CIRM)
    • Post Ipo Equity

      $42,900,000

    • Post Ipo Equity

      $56,749,988

    • Post Ipo Equity

      $10,290,000

    • Post Ipo Equity

      $32,000,000

    • Post Ipo Equity

      $8,000,000

    • Post Ipo Debt

      $20,000,000

      Post Ipo Debt Investors

      First Citizens Bank
    • IPO

      Unknown

    • Series Unknown

      $9,200,000

    • Series B

      $35,988,360

      Series B Investors

      Astellas Venture Management
      OVP Venture Partners
      Polaris Partners
      Venrock
      Arch Venture Partners
    • Debt Financing

      $1,000,000

    • Series B

      $30,000,000

      Series B Investors

      OVP Venture Partners
      Astellas Venture Management
      Sanofi
      Arch Venture Partners
      Polaris Partners
      Venrock
    • Series A

      $12,000,000

      Series A Investors

      Polaris Partners
      Arch Venture Partners
      Venrock
      OVP Venture Partners
    Funding info provided by Diffbot.

    Fate Therapeutics Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Fate Therapeutics.

    Recent reviews